A Phase Ii Study of Gemcitabine (Gemzar, Ly188011) in the Treatment of Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study
AuthID
P-00V-T5Y
P-00V-T5Y
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service